Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease
David J. Sherman, Jing Li
Molecules (2020) Vol. 25, Iss. 3, pp. 671-671
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Small Molecule NF-κB Pathway Inhibitors in Clinic
Venkataramanan Ramadass, Thamilselvan Vaiyapuri, Vinay Tergaonkar
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 14, pp. 5164-5164
Open Access | Times Cited: 168
Pathogenesis of allergic diseases and implications for therapeutic interventions
Ji Wang, Yumei Zhou, Honglei Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 143
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges
Grazia R. Tundo, Diego Sbardella, Anna Maria Santoro, et al.
Pharmacology & Therapeutics (2020) Vol. 213, pp. 107579-107579
Open Access | Times Cited: 87
Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors
Mahdi Pakjoo, Seyed Esmaeil Ahmadi, Mohammad Zahedi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Proteasome interaction with ubiquitinated substrates: from mechanisms to therapies
Xiang Chen, Zaw Min Htet, Erika M. López-Alfonzo, et al.
FEBS Journal (2020) Vol. 288, Iss. 18, pp. 5231-5251
Open Access | Times Cited: 50
Non-Hematologic Toxicity of Bortezomib in Multiple Myeloma: The Neuromuscular and Cardiovascular Adverse Effects
Elia Pancheri, Valeria Guglielmi, Grzegorz M. Wilczyński, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2540-2540
Open Access | Times Cited: 48
Optical control of targeted protein degradation
Martin Reynders, Dirk Trauner
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 969-986
Open Access | Times Cited: 40
Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
Dhananjay Yadav, Ji Yeon Lee, Nidhi Puranik, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1093-1093
Open Access | Times Cited: 25
Diagnostic and therapeutic potential of protease inhibition
Natalia Ćwilichowska, K. Świderska, Agnieszka Dobrzyń, et al.
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101144-101144
Closed Access | Times Cited: 25
ER-Resident Transcription Factor Nrf1 Regulates Proteasome Expression and Beyond
Jun Hamazaki, Shigeo Murata
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3683-3683
Open Access | Times Cited: 37
Advances in Proteasome Enhancement by Small Molecules
Dare E. George, Jetze J. Tepe
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1789-1789
Open Access | Times Cited: 27
Regulation of NRF1, a master transcription factor of proteasome genes: implications for cancer and neurodegeneration
Amy Northrop, Holly A. Byers, Senthil K. Radhakrishnan
Molecular Biology of the Cell (2020) Vol. 31, Iss. 20, pp. 2158-2163
Open Access | Times Cited: 30
Recent insights how combined inhibition of immuno/proteasome subunits enables therapeutic efficacy
Michael Basler, Marcus Groettrup
Genes and Immunity (2020) Vol. 21, Iss. 5, pp. 273-287
Closed Access | Times Cited: 28
More Than Just Cleaning: Ubiquitin-Mediated Proteolysis in Fungal Pathogenesis
Chengjun Cao, Chaoyang Xue
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 26
Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases
Jorge Ibañez-Vega, Constanza Vilchez, Karin Jimenez, et al.
Journal of Autoimmunity (2021) Vol. 123, pp. 102702-102702
Closed Access | Times Cited: 25
Ubiquitin: Not just a one‐way ticket to the proteasome, but a therapeutic dial to fine‐tune the molecular landscape of disease
Albert H. Kim, Peter M. Chiknas, Robin Lee
Clinical and Translational Medicine (2024) Vol. 14, Iss. 7
Open Access | Times Cited: 3
E3 ligases: a potential multi-drug target for different types of cancers and neurological disorders
Konda Mani Saravanan, K. Muthu, Prabhakar Meera, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 3, pp. 187-201
Closed Access | Times Cited: 15
The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer
S. C. Tripathi, Disha Vedpathak, Edwin J. Ostrin
Cells (2021) Vol. 10, Iss. 12, pp. 3587-3587
Open Access | Times Cited: 19
A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential
E.M. Huber, M. Groll
Cells (2021) Vol. 10, Iss. 8, pp. 1929-1929
Open Access | Times Cited: 18
The chemical biology of IL-12 productionviathe non-canonical NFkB pathway
Peter D. Koch, Mikaël J. Pittet, Ralph Weissleder
RSC Chemical Biology (2020) Vol. 1, Iss. 4, pp. 166-176
Open Access | Times Cited: 19
Synthesis, crystal structure, Hirshfeld surface, energy framework, NCI-RDG, theoretical calculations and molecular docking of (Z)4,4′-bis[-3-N-ethyl-2-N'-(phenylimino) thiazolidin-4-one] methane
Zohra Douaa Benyahlou, Fayssal Triki Baara, Salem Yahiaoui, et al.
Journal of Molecular Structure (2022) Vol. 1277, pp. 134781-134781
Closed Access | Times Cited: 12
CUL4-DDB1-CRBN E3 Ubiquitin Ligase Regulates Proteostasis of ClC-2 Chloride Channels: Implication for Aldosteronism and Leukodystrophy
Ssu-Ju Fu, Meng‐Chun Hu, Yi-Jheng Peng, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1332-1332
Open Access | Times Cited: 16
Fungal Secondary Metabolites as Inhibitors of the Ubiquitin–Proteasome System
Magdalena Staszczak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13309-13309
Open Access | Times Cited: 15
Evaluation of the NRF1-proteasome axis as a therapeutic target in breast cancer
Holly A. Byers, Amy N. Brooks, Janakiram R. Vangala, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Discovery of selective fragment-sized immunoproteasome inhibitors
Levente Kollár, Martina Gobec, Bence Szilágyi, et al.
European Journal of Medicinal Chemistry (2021) Vol. 219, pp. 113455-113455
Closed Access | Times Cited: 13
Page 1 - Next Page

Scroll to top